Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin
- PMID: 32354918
- PMCID: PMC7279783
- DOI: 10.21873/invivo.11901
Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin
Abstract
Background/aim: Peritumoral clefting is one of the main histologic features of basal cell carcinoma of the skin (BCC). The aim of the study was to analyze the expression of MMP-2 and MMP-9 both in cells of basal cell carcinoma and in the adjacent stroma and to correlate the findings of immunohistochemical analysis with the presence of peritumoral clefting.
Patients and methods: The study was made on archival material comprising 48 cases of BCC. These were scanned for the presence of peritumoral clefts. The results of immunohistochemical staining for MMP-2 and MMP-9 were determined semiquantitatively using immunohistochemical staining index (ISI).
Results: Peritumoral retractions were found in 40 BCC cases. Positive immunohistochemical reaction for MMP-2 in tumor cells was found in 47 cases and in all cases in the adjacent stroma. Positive immunostaining for MMP-9 in BCC tumor cells was observed in 37 cases and in all cases in the adjacent stroma. There was no statistically significant association between peritumoral retractions and expression of MMPs. A statistically significant correlation was found in the expression of both MMP-2 and MMP-9 between the tumor and the stroma.
Conclusion: Tumor cells elaborate MMP-2 and -9, but they also produce some other factors that may induce production of MMPs in adjacent stromal cells. The role of MMPs in the development of peritumoral clefts could not be confirmed.
Keywords: Basal cell carcinoma; MMP-2; MMP-9; histopathology; peritumoral clefting.
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Conflict of interest statement
The Authors have no conflicts of interest to declare regarding this study.
Figures
Similar articles
-
[Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):369-73. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22883459 Chinese.
-
High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.Pathol Oncol Res. 2018 Jul;24(3):567-574. doi: 10.1007/s12253-017-0279-2. Epub 2017 Jul 27. Pathol Oncol Res. 2018. PMID: 28752222
-
Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma.Mol Biol Rep. 2016 Oct;43(10):1027-33. doi: 10.1007/s11033-016-4040-9. Epub 2016 Jul 12. Mol Biol Rep. 2016. PMID: 27406386 Free PMC article.
-
Differential expression of stromal MMP-1, MMP-9 and TIMP-1 in basal cell carcinomas of immunosuppressed patients and controls.Virchows Arch. 2008 Jan;452(1):83-90. doi: 10.1007/s00428-007-0526-0. Epub 2007 Nov 22. Virchows Arch. 2008. PMID: 18034264
-
Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma.Biomolecules. 2021 Jun 17;11(6):903. doi: 10.3390/biom11060903. Biomolecules. 2021. PMID: 34204372 Free PMC article. Review.
Cited by
-
Skin Cancer Microenvironment: What We Can Learn from Skin Aging?Int J Mol Sci. 2023 Sep 13;24(18):14043. doi: 10.3390/ijms241814043. Int J Mol Sci. 2023. PMID: 37762344 Free PMC article. Review.
-
Characterization of SHH, SOX3, WNT3A and WNT9B Proteins in Human Non-Syndromic Cleft Lip and Palate Tissue.Dent J (Basel). 2023 Jun 9;11(6):151. doi: 10.3390/dj11060151. Dent J (Basel). 2023. PMID: 37366674 Free PMC article.
-
CORRELATION OF EXPRESSION OF TGF- β AND MMP2 BETWEEN PROSTATIC ADENOCARCINOMA AND ADJACENT UNAFFECTED PARENCHYMA.Acta Clin Croat. 2022 Oct;61(Suppl 3):9-14. doi: 10.20471/acc.2022.61.s3.1. Acta Clin Croat. 2022. PMID: 36938549 Free PMC article.
-
Nodular and Micronodular Basal Cell Carcinoma Subtypes Are Different Tumors Based on Their Morphological Architecture and Their Interaction with the Surrounding Stroma.Diagnostics (Basel). 2022 Jul 5;12(7):1636. doi: 10.3390/diagnostics12071636. Diagnostics (Basel). 2022. PMID: 35885545 Free PMC article.
-
Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.Front Med (Lausanne). 2022 Apr 29;9:879500. doi: 10.3389/fmed.2022.879500. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572966 Free PMC article. Review.
References
-
- Chicheł A, Skowronek J. Contemporary management of skin cancer-dermatology, surgery or radiotherapy. Contemp Oncol. 2005;9:429–435.
-
- Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6–10. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous